Cargando…
Revisiting the Radiobiology of Targeted Alpha Therapy
Targeted alpha therapy (TAT) using alpha particle-emitting radionuclides is in the spotlight after the approval of (223)RaCl(2) for patients with metastatic castration-resistant prostate cancer and the development of several alpha emitter-based radiopharmaceuticals. It is acknowledged that alpha par...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353448/ https://www.ncbi.nlm.nih.gov/pubmed/34386508 http://dx.doi.org/10.3389/fmed.2021.692436 |